X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2152) 2152
Publication (276) 276
Book Review (17) 17
Book Chapter (8) 8
Book / eBook (7) 7
Conference Proceeding (4) 4
Dissertation (4) 4
Magazine Article (4) 4
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1687) 1687
male (1173) 1173
cardiomegaly - prevention & control (1146) 1146
rats (1037) 1037
index medicus (888) 888
humans (831) 831
cardiomegaly - pathology (567) 567
mice (562) 562
hypertrophy (530) 530
cardiac & cardiovascular systems (518) 518
cardiomegaly - etiology (511) 511
cardiomegaly - physiopathology (497) 497
cardiomegaly - metabolism (495) 495
myocardium - pathology (433) 433
heart (418) 418
female (388) 388
disease models, animal (385) 385
cardiac hypertrophy (355) 355
heart-failure (354) 354
myocardium - metabolism (351) 351
peripheral vascular disease (340) 340
rats, sprague-dawley (340) 340
hypertension (328) 328
heart failure (294) 294
fibrosis (290) 290
blood pressure - drug effects (281) 281
pharmacology & pharmacy (275) 275
cells, cultured (267) 267
physiology (260) 260
myocytes, cardiac - metabolism (259) 259
myocytes, cardiac - drug effects (251) 251
mice, inbred c57bl (249) 249
cardiomegaly - genetics (248) 248
cardiomegaly - chemically induced (247) 247
hypertension - complications (242) 242
myocytes, cardiac - pathology (235) 235
cardiomegaly - drug therapy (233) 233
heart enlargement (229) 229
time factors (213) 213
expression (212) 212
rats, wistar (207) 207
hypertension - drug therapy (202) 202
oxidative stress (198) 198
cardiac-hypertrophy (195) 195
signal transduction (190) 190
hypertension - physiopathology (189) 189
mice, knockout (186) 186
echocardiography (185) 185
activation (181) 181
blood pressure (181) 181
rats, inbred shr (177) 177
left-ventricular hypertrophy (175) 175
cell biology (174) 174
cardiovascular system (172) 172
apoptosis (169) 169
middle aged (168) 168
adult (159) 159
gene-expression (159) 159
risk factors (159) 159
cardiomegaly - enzymology (158) 158
rodents (158) 158
signal transduction - drug effects (158) 158
myocardial-infarction (157) 157
cardiomyocytes (156) 156
heart - drug effects (154) 154
heart diseases (153) 153
phosphorylation (150) 150
prevention (148) 148
gene expression (145) 145
physiological aspects (144) 144
cardiomegaly - complications (143) 143
mice, transgenic (142) 142
angiotensin ii (138) 138
angiotensin-ii (138) 138
research (137) 137
animals, newborn (135) 135
heart failure - prevention & control (131) 131
pressure-overload (131) 131
blood-pressure (129) 129
electrocardiography (129) 129
cardiomyopathy (128) 128
angiotensin (124) 124
article (124) 124
biochemistry & molecular biology (121) 121
inhibition (117) 117
health aspects (116) 116
medicine, research & experimental (115) 115
aged (114) 114
multidisciplinary sciences (114) 114
research article (110) 110
ventricular remodeling - drug effects (110) 110
proteins (109) 109
rna, messenger - metabolism (108) 108
hypertension - prevention & control (107) 107
cardiomegaly (106) 106
heart failure - physiopathology (106) 106
myocardium - enzymology (104) 104
cardiomegaly - diagnostic imaging (102) 102
heart - physiopathology (100) 100
hematology (100) 100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2014) 2014
German (31) 31
Japanese (31) 31
French (23) 23
Russian (21) 21
Chinese (14) 14
Italian (12) 12
Polish (5) 5
Spanish (5) 5
Czech (4) 4
Portuguese (4) 4
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Delise, P and Bertocchi, F and Maiocchi, G and Geraci, E and Correale, E and Lombardi, F and Mugelli, A and Urso, R and Scardi, S and Fabbri, G and Bartolomei, B and Barbato, G and Carbonieri, E and Ciricugno, S and Cosmi, F and Pratola, C and Rossi, M.G and Sciarra, L and Zeni, P and Ceseri, M and Atzori, A and Bambi, F and Baviera, M and Bianchini, F and Fenicia, E and Gianfriddo, M and Lonardo, G and Luise, A and Nota, R and Orlando, M.E and Petrolo, R and Pierattini, C and Pierota, V and Ragno, A and Serio, C and Tafi, A and Tellaroli, E and Masson, S and Vago, T and Gramenzi, S and Orso, F and Suliman, I and Nicolis, E and Casola, C and Dall'Osso, D and Gorini, M and Bianchini, E and Cabiddu, S and Cangioli, I and Carnaghi, A and Cipressa, M.L and Cipressa, L and Galbiati, L and Lorimer, A and Priami, P and Moccetti, T and Vaghi, F and Capello, A.F and Rossetti, G and Viada, E and Morena, L and Delucchi, M and Reynaud, S.G and Allemano, P and Massobrio, N and Gavazzi, A and Taddei, F and Mor, D.A and Bortolini, F and Lorini, M and Inama, G and Durin, O and Pirelli, S and Spotti, A and Procopio, R and Cuzzucrea, D and Gentile, G and Margonato, A and Bassanelli, G and Tavazzi, L and Buzzi, M.P and Rordorf, R and Gualco, A and Opasich, C and Gronda, E and Genovese, L and Mattioli, R and Donatelli, F and Uriarte, J.A and Rauhe, W and Bertagnolli, C and Canestrini, S and Stefenelli, C and Cioffi, G and Giovanelli, C and Rigatelli, G and Boni, S and Pasini, A and Sitta, N and Sacchetta, A and ... and The GISSI-AF Investigators and GISSI AF Investigators and GISSI-AF Investigators
The New England Journal of Medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1606 - 1617
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 02/2007, Volume 292, Issue 2, pp. 736 - 742
Cardiac remodeling, which typically results from chronic hypertension or following an acute myocardial infarction, is a major risk factor for the development... 
Cardiac fibrosis | Myocyte hypertrophy | Transforming growth factor-β | FIBROSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | MYOCARDIAL-INFARCTION | myocyte hypertrophy | SPONTANEOUSLY HYPERTENSIVE-RATS | FAILURE | transforming growth factor-beta | ACE2 | cardiac fibrosis | CONVERTING ENZYME-2 | GROWTH | HEART FUNCTION | PERIPHERAL VASCULAR DISEASE | RECEPTOR MAS | EXPRESSION | Receptors, G-Protein-Coupled - metabolism | Cardiomegaly - etiology | Cardiomegaly - pathology | Male | Peptide Fragments - pharmacology | Time Factors | Hypertension - chemically induced | Myocardium - metabolism | Angiotensin I - pharmacology | Blood Pressure - drug effects | Receptors, G-Protein-Coupled - drug effects | Disease Models, Animal | Proto-Oncogene Proteins - metabolism | Angiotensin II - pharmacology | Peptide Fragments - metabolism | Proto-Oncogene Proteins - drug effects | Cardiomegaly - physiopathology | Rats | Myocardium - pathology | Angiotensin II - analogs & derivatives | Angiotensin I - metabolism | Rats, Sprague-Dawley | Transforming Growth Factor beta - blood | Hypertension - physiopathology | Animals | Cardiomegaly - prevention & control | Receptor, Angiotensin, Type 2 - metabolism | Analysis of Variance | Receptor, Angiotensin, Type 1 - metabolism | Fibrosis | Heart - drug effects | Hypertension - complications | Ventricular Remodeling - drug effects | Cardiomegaly - metabolism
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 42, pp. 17035 - 17040
Journal Article
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 09/2015, Volume 465, Issue 1, pp. 159 - 164
ApoE−/− mice fed a high fat and high cholesterol (HFHC) diet (20% fat and 1.25% cholesterol) from 12 weeks of age to 36 weeks revealed an age-dependent... 
Cardiac hypertrophy | Lactosylceramide | Glycosphingolipids | Atherosclerotic heart disease | OXIDATIVE STRESS | STRETCH | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYPERLIPIDEMIA | ATHEROSCLEROSIS | LEFT-VENTRICULAR HYPERTROPHY | BIOPHYSICS | DISEASE | MASS | HYPERTENSION | Apolipoproteins E - deficiency | Natriuretic Peptide, Brain - metabolism | Cardiomegaly - etiology | Diet, High-Fat - adverse effects | Cardiomegaly - pathology | Male | Galactosyltransferases - genetics | Glucosyltransferases - metabolism | Atrial Natriuretic Factor - genetics | Galactosyltransferases - antagonists & inhibitors | Phosphorylation - drug effects | Heart Ventricles - pathology | Glucosyltransferases - genetics | Glucosyltransferases - antagonists & inhibitors | Gene Expression | Natriuretic Peptide, Brain - genetics | Atrial Natriuretic Factor - metabolism | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Cardiotonic Agents - pharmacology | Galactosyltransferases - metabolism | Mice, Knockout | Myocytes, Cardiac - pathology | Animals | Cardiomegaly - prevention & control | Myocytes, Cardiac - drug effects | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Apolipoproteins E - genetics | Glycosphingolipids - antagonists & inhibitors | Glycosphingolipids - metabolism | Myocytes, Cardiac - metabolism | Mitogen-Activated Protein Kinases - genetics | Heart Ventricles - metabolism | Mice | Cardiomegaly - genetics | Cholesterol - adverse effects | Heart Ventricles - drug effects | Mitogen-Activated Protein Kinases - metabolism | Prevention | Heart | Heart enlargement | Diastereomers | Analysis | Apolipoproteins | Gene expression | Gangliosides
Journal Article
Journal Article
Science, ISSN 0036-8075, 9/1998, Volume 281, Issue 5383, pp. 1690 - 1693
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, pp. e82287 - e82287
Background: Emerging evidence showed the beneficial effect of acidic fibroblast growth factor (aFGF) on heart diseases. The present study investigated whether... 
HEART | FACTOR FAMILY | APOPTOSIS | HYPERTROPHY | MYOCARDIAL FIBROSIS | MULTIDISCIPLINARY SCIENCES | CARDIAC MYOCYTES | DNA-DAMAGE | RATS | DYSFUNCTION | NF-KAPPA-B | Diabetic Cardiomyopathies - drug therapy | Humans | Body Weight - drug effects | Cardiomegaly - pathology | Male | RNA, Messenger - metabolism | Diabetic Cardiomyopathies - physiopathology | Heart Rate - drug effects | Diabetic Cardiomyopathies - prevention & control | Blood Pressure - drug effects | Cell Line | RNA, Messenger - genetics | Cardiomegaly - drug therapy | Rats | Rats, Sprague-Dawley | Cardiomegaly - complications | Gene Expression Regulation - drug effects | Animals | Fibroblast Growth Factor 1 - pharmacology | Fibrosis | Diabetic Cardiomyopathies - pathology | Fibroblast Growth Factor 1 - therapeutic use | Mice | DNA Damage | Oxidative Stress - drug effects | Blood Glucose - metabolism | Cardiomegaly - genetics | Fibroblast Growth Factor 1 - administration & dosage | Mitogens | Hypertension | Heart | Fibronectins | Medical research | Oxidative stress | RNA | Streptozocin | Cardiomyopathy | Glucose | Dextrose | Medicine, Experimental | Fibroblast growth factors | Heart diseases | Pediatrics | Fibroblast growth factor | Cell culture | Reactive oxygen species | Heart surgery | DNA damage | Mitochondrial DNA | Western blotting | Fibronectin | Mimicry | Angiogenesis | Toxicology | Cell growth | Ischemia | Rodents | Fibroblasts | Blood pressure | Oxidation | Deoxyribonucleic acid--DNA | Damage assessment | Departments | Fibroblast growth factor 1 | Acidic oxides | Diabetes mellitus | Cardiomyocytes | Pharmacology | Gene expression | Coronary artery disease | Endothelial cells | Studies | Pathology | Pharmacy | Microvasculature | Asian Americans | Diabetes | Laboratory animals | Cardiovascular diseases | Hypertrophy | Apoptosis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article